Replimune Group, Inc.

REPL ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2018

Total Assets: $65.2M

Liabilities Breakdown FY2018

Total Liabilities: $6.9M